Hikal Fair Value
Hikal (HIKAL) average fair value is ₹472.61 across 5 valuation models — P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹221.32 (+113.54%), fair value range ₹2.07–₹1350.34. Examine HIKAL quarterly results for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
HIKAL Fair Value vs Current Price — Valuation Summary
HIKAL average fair value, fair value range, price gap and valuation status across 5 models: P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit Hikal stock price NSE.
P/B Based Valuation
Dividend Discount Model
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
HIKAL Fair Value Analysis — Data Sources & Coverage
Hikal financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. See HIKAL price to book ratio to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
HIKAL vs Healthcare Sector Peers — P/E, P/B & Market Cap
Hikal P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 40.02 | 22.33 | ₹7,891 |
| Accretion Pharmaceuticals | ACCPL | 13.72 | 2.43 | ₹131 |
| Par Drugs & Chemical | PAR | 8.67 | 1.01 | ₹111 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.